Delivery Order SPE2DB22D9304-SPE2DB24FSSJ2

Award Date 11/15/23
Potential Completion Date 11/16/23
Potential Value $11K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at thirty-two thousand eight hundred seventeen dollars and eighty-two cents ($32,817.82) by the Defense Logistics Agency to supply sixty (60) 15 mg Jakafi tablets. The delivery order was issued against DMS Pharmaceutical Group's indefinite delivery contract with the Defense Logistics Agency to provide pharmaceuticals and medical supplies with a potential value of up to five million dollars ($5,000,000)...
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at forty-three thousand seven hundred seventy-four dollars and eight cents ($43,774.08) by the Defense Logistics Agency to supply Jakafi 10 mg tablets, 60 count. The delivery order was issued against DMS Pharmaceutical Group's indefinite delivery contract with the Defense Logistics Agency to provide pharmaceuticals and medical supplies with a potential value of up to five million dollars through December...
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order for $10,937.15 under an indefinite delivery contract with the Defense Logistics Agency. The delivery order is for 60 tablets of Jakafi 15 mg to support medical treatment facilities operated by the Defense Logistics Agency. DMS Pharmaceutical Group will provide the pharmaceutical products from their location in Park Ridge, Illinois, with delivery required by December 12, 2023. As a woman-owned small business, DMS...
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at $21,874.30 by the Defense Logistics Agency to provide 60 tablets of Jakafi 15 mg for use by military treatment facilities. The order is being issued against DMS Pharmaceutical Group's existing indefinite delivery contract with the Defense Logistics Agency to supply various pharmaceutical items and medical supplies with a total potential value of up to $5 million through December 2025. No set-aside...
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order for $22,040.98 under the Defense Logistics Agency Troop Support Medical indefinite delivery contract to provide Jakafi 25 mg tablets. The delivery order requires 60 tablets to be delivered to a facility in Park Ridge, Illinois by May 23, 2023. DMS Pharmaceutical Group holds this pharmaceutical prime vendor contract with the Defense Logistics Agency to directly supply prescription medications and services in...
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order against the Defense Logistics Agency Troop Support Medical pharmaceutical prime vendor contract to supply Jakafi 10 mg tablets in the amount of sixty tablets. The order has a potential value of thirty-two thousand eight hundred thirty dollars and fifty-six cents ($32,830.56) and requires completion by December 18, 2023. DMS Pharmaceutical Group will deliver the pharmaceutical products to the place of performance...
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at thirty-two thousand eight hundred forty-two dollars and two cents ($32,842.02) by the Defense Logistics Agency Troop Support Medical to provide five hundred sixty (560) tablets of Jakafi 5 mg for the period ending November 30, 2023. This delivery order was issued against DMS Pharmaceutical Group's existing indefinite delivery contract with the Defense Logistics Agency, which has a potential value of up...
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at eleven thousand one hundred twenty-four dollars and nineteen cents ($11,124.19) by the Defense Logistics Agency Troop Support Medical. The order is for sixty (60) tablets of Jakafi 10 mg to be delivered by December 5, 2023. No set-aside designation was used for this award. DMS Pharmaceutical Group is a woman-owned small business and woman-owned business located in Park Ridge, Illinois that holds numerous...
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at thirty-two thousand eight hundred forty-two dollars and two cents ($32,842.02) by the Defense Logistics Agency Troop Support Medical to provide Jakafi 5 mg tablets, 60 count. The order was awarded on November 13, 2023 and is required to be completed by November 14, 2023. No set-aside designation was applied to this procurement. DMS Pharmaceutical Group is a woman-owned small business and woman-owned...
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at eleven thousand twenty dollars and forty-nine cents ($11,020.49) by the Defense Logistics Agency. This order was issued against DMS Pharmaceutical Group's existing indefinite delivery contract to supply pharmaceutical items and medical products to support military treatment facilities worldwide. Under this particular order, DMS Pharmaceutical Group will provide sixty tablets of Jakafi, a medication used to...
  • SPE2DB22D9304
    Indefinite Delivery Contract
  • SPE2DB22D9304-SPE2DB24FSSJ2
    Delivery Order

DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order for $10,943.52 under an indefinite delivery contract with the Defense Logistics Agency to supply Jakafi 10 mg tablets. As a woman-owned small business, DMS Pharmaceutical Group will deliver 60 tablets of Jakafi to the Park Ridge, Illinois location of the Defense Logistics Agency Troop Support Medical. The completion date is listed as November 16, 2023. This delivery order was awarded without a set-aside designation against DMS Pharmaceutical Group's existing pharmaceutical prime vendor contract with the Defense Logistics Agency, which has a potential value of up to $5 million through December 2025. This contract enables DMS Pharmaceutical Group to directly supply prescription medications and services in support of military treatment pharmacies globally.

Generated 2/14/24, 10:09 AM